Recent Advances in the Prevention of Respiratory Syncytial Virus in Pediatrics

• 2024

  Log in to bookmark this resource.

  Log in
• Madeline Lipp; Kerry Empey
PMID: 38299987DOI: https://dx.doi.org/10.1097/MOP.0000000000001336

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This review article highlights new developments in respiratory syncytial virus (RSV) prevention in pediatric patients and safety considerations for clinical trials. It describes two new treatments approved in 2023: a vaccine for pregnant women and an antibody treatment, both reducing RSV-related infections. The field is growing with more trials exploring different methods to protect infants and kids from RSV. While these advancements are promising, it emphasizes the need for careful study of risks and long-term safety through thorough clinical trials and monitoring after approval to ensure safe use of these prevention strategies over time.

---

Tags

Focus Area: Infectious Disease

Audiences: Nurses; Physicians; Public Health Professionals

Emergency Management Stage: Preparedness (Prevention / Protection)

Collection: Nirsevimab Library

Keywords: Hospitalization; Immunization; Infant; Infant, Newborn; Pediatrics; Pregnant Women; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; United States; Viral Vaccines; Respiratory Syncytial Virus Vaccines

Institutions: University of Pittsburgh School of Medicine; University of Pittsburgh

---

More like this

Recent Advances in the Prevention of Respiratory Syncytial Virus in Pediatrics 2024 · University of Pittsburgh School of Medicine, University of Pittsburgh Ethical Obligations Regarding Short-Term Global Health Clinical Experiences: An American College of Physicians Position Paper 2018 · Johns Hopkins University, U.S. Department of Veterans Affairs, National Center for Ethics in Health Care, University of California –San Diego School of Medicine, University of California, San Diego, Virginia Mason Medical Center Paediatric Emergency Triage, Assessment and Treatment (ETAT) – Preparedness for Implementation at Primary Care Facilities in Malawi 2021 · Karolinska Institutet, University of Malawi, University College London, Malawi Epidemiology and Intervention Research Unit, Parent and Child Health Initiative Trust, Liverpool School of Tropical Medicine

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---